BIOCRYST PHARMACEUTICALS, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2017
Total Assets: $178.3M
Liabilities Breakdown FY2017
Total Liabilities: $94.5M
Asset Breakdown
Total Assets: $178.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $50.3M | 28.2% |
| Accounts Receivable | $6.1M | 3.4% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $9.5M | 5.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $112.3M | 63.0% |
Liabilities Breakdown
Total Liabilities: $94.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $6.3M | 6.7% |
| Long-Term Debt | $23.0M | 24.3% |
| Other Liabilities | $65.2M | 69.0% |